Ayahuasca Research Reveals a Wider World of Plant Diversity

Why Plant Identification Matters for Ayahuasca Research

Ayahuasca is often described as a combination of two Amazonian plants: a vine and a leaf. That explanation is useful, but it can conceal a much richer botanical history. Different communities recognize different plants, varieties, and preparations, while researchers have concentrated on a relatively narrow portion of that diversity.

A new review, “Unveiling Ayahuasca: Comprehensive Study of Botanical and Chemical Diversity,” examines this gap by bringing together historical literature, chemical research, and preserved botanical specimens.¹ Accepted by the Journal of Ethnopharmacology, the paper offers a constructive message: better knowledge of the plants involved could make ayahuasca research more reliable without reducing traditional practices to one standardized formula.

The opportunity begins with a basic question that can be surprisingly difficult to answer: when two studies investigate ayahuasca, are they investigating comparable preparations?

Ayahuasca Is More Than a Two-Plant Formula

The familiar combination pairs Banisteriopsis caapi with Psychotria viridis. The vine supplies compounds called beta-carbolines, including harmine and harmaline, while the leaves supply N,N-dimethyltryptamine, commonly known as DMT. Another documented leaf ingredient is Diplopterys cabrerana.

Some beta-carbolines inhibit monoamine oxidase A, an enzyme involved in breaking down DMT. This interaction helps explain why the combined preparation can produce effects when consumed orally. However, explaining that central interaction does not fully describe the beverage’s botanical or chemical composition.

The review identified 24 reported vine species and 13 reported leaf species, alongside 80 species described as occasional additives. Those numbers represent associations assembled from different sources, not a list of equally verified or interchangeable ingredients.

That distinction is essential. The researchers evaluated supporting evidence rather than accepting every historical name as confirmation. Some records combined published documentation with preserved plant specimens. Others rested on limited annotations or lacked adequate support.

What the Review Actually Confirmed

The following table summarizes the review’s evidence categories. “Historically confirmed” describes support for an ingredient’s documented association with ayahuasca, not proof of clinical safety or therapeutic benefit.

The result is more useful than an impressive headline about dozens of ingredients. It separates established documentation from questions that future investigations can resolve.

Why Botanical Specimens Matter for Psychedelic Science

A botanical voucher is a preserved reference specimen deposited in a collection such as a herbarium. It allows other researchers to examine the plant associated with a study and check whether its identification was correct.

Without that reference, a chemical measurement can become disconnected from its supposed source. If researchers later question the identification, they may have no original material available to reassess. A species name in a methods section cannot always resolve that uncertainty.

Traditional names introduce another layer of complexity. The review compiled 119 B. caapi ethnotaxa and two P. viridis ethnotaxa. Ethnotaxa are categories recognized within traditional classification systems. They should not be counted as 121 additional scientific species.

Such classifications can preserve distinctions that matter to communities even when formal botanical taxonomy groups the plants together. The productive question is how those distinctions relate to observable characteristics and chemistry, rather than whether one naming system should replace another.

A 2026 machine learning study of ayahuasca vine leaves explored whether leaf morphology could recover traditional classifications. Its findings suggest that leaf characteristics contain relevant signals, although agreement with earlier classifications was partial. Technology can support investigation, but that does not make an automated label a substitute for botanical expertise or community knowledge.

Better Documentation Could Make Ayahuasca Studies Easier to Compare

The review is a narrative synthesis, not a clinical trial. It does not establish that a particular preparation treats depression or that a less-studied plant improves outcomes. Its contribution lies further upstream: identifying what researchers need to document before drawing meaningful comparisons.

Consider two hypothetical studies reporting different results. Both call their intervention ayahuasca, but one records verified plant identities and detailed chemical measurements, while the other provides only a common name. Differences might reflect participants, setting, preparation, or composition. Without adequate documentation, those possibilities become harder to separate.

A useful extension of the review is to think of each research preparation as needing a record that connects its biological origin with its measured chemistry. That record could include:

• Verified plant identities and accessible reference specimens.
• Preparation and storage conditions linked to the tested batch.
• Chemical measurements taken from the administered preparation.
• Documented cultural context and appropriate attribution.

This would help researchers understand differences rather than simply average them away. Variation can become informative when it is measured and traceable.

Ayahuasca Quality Depends on Chemistry and Preparation

Botanical verification is necessary, but it is not sufficient. A correctly identified plant does not guarantee that every preparation made from it has the same chemical profile.

The review describes variation in published alkaloid measurements and discusses storage studies in which compounds showed different patterns of stability. It also notes that chemical research remains heavily concentrated on B. caapi and P. viridis, leaving many other historically associated plants poorly investigated.

A recently published validation study of psychedelic compound testing demonstrates another part of the emerging toolkit. Researchers developed and evaluated an analytical method for identifying and measuring psychoactive compounds across botanical materials and preparations, including brewed tea. Such methods offer tools for characterization; they do not establish that a tested product is medically effective.

Cannabis readers will recognize the broader principle. MyCannabis coverage of how cannabis drying shapes chemical quality explains how processing can change a plant product after harvest. The relevant parallel is that biological identity and production history both matter. It does not imply that cannabis and ayahuasca share the same pharmacology.

For ayahuasca research, pairing botanical verification with chemical testing could reduce uncertainty about what participants actually received. That would strengthen interpretation of both encouraging and disappointing findings.

Standardizing Research Without Erasing Traditional Diversity

Standardization can mean two different things: making every preparation identical, or making descriptions and measurements consistent enough to understand differences. The second approach offers a particularly useful starting point.

A clinical investigation may require a tightly specified preparation to answer a particular question. That requirement does not establish that every traditional ceremony should use the same formula, or that findings from the trial apply to every beverage called ayahuasca.

The review emphasizes that historical collections preserve valuable traditional knowledge, but frequently lack details about who supplied it, how it was obtained, or whether consent and benefit-sharing arrangements existed. Future research can improve on that record through respectful collaboration and clearer attribution.

This suggests an important principle: preserving a specimen and respecting its knowledge holders should be complementary responsibilities. Scientific traceability becomes stronger when the cultural history attached to a plant is documented responsibly.

A Stronger Foundation for the Next Phase of Psychedelic Research

Better plant records will not answer every question about ayahuasca. Outcomes also depend on the people involved and the circumstances surrounding an experience. Recent MyCannabis reporting on psychedelic therapist experience and patient trust illustrates why credible care requires evaluating human factors alongside substances.

The distinctive contribution of this review is to show that botanical uncertainty deserves similar attention. A familiar beverage name can hide differences that are relevant to research, while historical records can point toward questions that modern analytical methods are now better equipped to investigate.

The promising next step is therefore concrete: connect verified plants, measured preparations, transparent methods, and respectful community partnerships. That foundation could help researchers learn more from ayahuasca’s diversity while making their conclusions more precise about which preparation, population, and context they actually describe.

References:

¹ Saavedra-Saenz, Y. C., e Silva, M. S., Estrada Semprun, O. E., Silveira, D., Gomes, S. M., Biazatti, S. C., & de Oliveira, R. C. (2026). Unveiling ayahuasca: Comprehensive study of botanical and chemical diversity. Journal of Ethnopharmacology, Article 122404. Advance online publication. https://doi.org/10.1016/j.jep.2026.122404